Name: REGULUS THERAPEUTICS INC (RGLS) Stock
Brand: REGULUS THERAPEUTICS INC
Rating: 6.5 (3 reviews)

RGLS Latest News, Press Relases and Analysis

All

Press Releases

5 months ago - By: Yahoo Finance - Mentions: NVS NOVN

Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion

6 months ago - By: Halper Sadeh LLC - Mentions: KRON SSBK XAGE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of Shareholders

6 months ago - By: Brodsky & Smith LLC - Mentions: SSBK KRON XAGE

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (Nasdaq - XAGE), Southern States Bancshares, Inc. (Nasdaq

7 months ago - By: Zacks Investment Research

Should You Buy Regulus (RGLS) After Golden Cross?

7 months ago - By: Regulus Therapeutics Inc.

Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates

7 months ago - By: Kahn Swick & Foti, LLC

REGULUS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Regulus Therapeutics Inc. - RGLS

7 months ago - By: Benzinga - Mentions: GKOS PSN

This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

7 months ago - By: Brodsky & Smith LLC - Mentions: KRON COEP PPBI COLB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

7 months ago - By: Stocktwits - Mentions: NVS PLX ZVRA ESPR ...

Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead

7 months ago - By: Benzinga - Mentions: RGC BCLI ZYXI CLRB ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

7 months ago - By: Stocktwits - Mentions: VTI IWM NVS HUM

Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis

7 months ago - By: Halper Sadeh LLC

RGLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Regulus Therapeutics Inc. Is Fair to Shareholders

7 months ago - By: Bloomberg - Mentions: NVS

Novartis to Buy Regulus Therapeutics for as Much as $1.7 Billion

7 months ago - By: Ademi & Fruchter LLP

Shareholder Alert: The Ademi Firm Investigates Whether Regulus Therapeutics Inc. Is Obtaining a Fair Price for Its Public Shareholders

7 months ago - By: Regulus Therapeutics Inc.

Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG

7 months ago - By: Yahoo Finance - Mentions: MP DIBS VERV NFLX ...

Why MP Materials Stock Was a Massive Winner This Week

7 months ago - By: Yahoo Finance - Mentions: MBOT HFFG COMP HURA ...

Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts?

8 months ago - By: Regulus Therapeutics Inc.

Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit

8 months ago - By: Regulus Therapeutics Inc.

Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

8 months ago - By: Regulus Therapeutics Inc.

Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates

9 months ago - By: Regulus Therapeutics Inc.

Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference

10 months ago - By: Regulus Therapeutics Inc.

REGULUS THERAPEUTICS INC (RGLS) Stock News

RGLS Latest News, Press Relases and Analysis

Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (Nasdaq - XAGE), Southern States Bancshares, Inc. (Nasdaq

Should You Buy Regulus (RGLS) After Golden Cross?

Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates

REGULUS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Regulus Therapeutics Inc. - RGLS

This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead

12 Health Care Stocks Moving In Wednesday's Intraday Session

Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis

RGLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Regulus Therapeutics Inc. Is Fair to Shareholders

Novartis to Buy Regulus Therapeutics for as Much as $1.7 Billion

Shareholder Alert: The Ademi Firm Investigates Whether Regulus Therapeutics Inc. Is Obtaining a Fair Price for Its Public Shareholders

Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG

Why MP Materials Stock Was a Massive Winner This Week

Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts?

Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit

Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates

Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference

Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference